Karakteristik Pasien Urologi Rsud Undata Provinsi Sulawesi Tengah Tahun 2021 - 2023: Characteristics of Urology Patients at Undata Hospital, Central Sulawesi Province, 2021 - 2023

Muhammad Hapsi Sukarni

doi:10.52103/jahr.v5i1.1731

Authors

Muhammad Hapsi Sukarni Rumah Sakit Umum Daerah Undata, Provinsi Sulawesi Tengah, Indonesia

DOI:

https://doi.org/10.52103/jahr.v5i1.1731

Keywords:

Karakteristik, urologi, pasien, RSUD Undata

Abstract

Abstract

Latar Belakang: Patologi saluran kemih dan genital bertanggung jawab atas beban penyakit yang cukup besar di seluruh dunia, menyebabkan hilangnya produktivitas, peningkatan beban biaya kesehatan, dan penurunan kualitas hidup (QoL) pada individu terdampak.

Tujuan: Menyajikan karakteristik pasien urologi selama tiga tahun terakhir untuk menentukan strategi komprehensif pengelolaan penyakit terkait.

Metode: Penelitian retrospektif cross-sectional terhadap pasien di Poliklinik Urologi RSUD Undata, berdasarkan data rekam medis periode Januari 2021 hingga Desember 2023, data dikumpulkan dengan teknik total sampling.

Hasil: Penelitian ini terdiri dari 5223 total pasien. Distribusi berdasarkan usia meliputi; 31,4% pada usia 61-70 tahun, 24,3% pada usia 51-60 tahun, 15,1% pada usia >70 tahun, 12,2% pada usia 41-50 tahun. Sebanyak 7,3% pada usia 31-40 tahun, 5,1% pada usia 21-30 tahun, dan masing-masing 2,2% pada usia <10 tahun dan 11-20 tahun. Distribusi berdasarkan jenis kelamin meliputi; 81,2% pasien laki-laki dan 18,8% pasien perempuan. Distribusi berdasarkan diagnosis meliputi; sebanyak 2988 subjek penelitian yaitu 57,2% dengan diagnosis hiperplasia prostat, 16,7% dengan diagnosis batu ginjal, dan 6,8% dengan diagnosis batu ureter.

Kesimpulan: Pasien di Poliklinik Urologi RSUD Undata umumnya lanjut usia, terbanyak pada rentang usia 61-70 tahun, diikuti rentang usia 51-60 tahun, sebagian besar pasien laki-laki dan diagnosis terbanyak adalah hiperplasia prostat, batu ginjal, dan batu ureter.

ABSTRACT

Background: Urinary and genital tract pathologies are responsible for a substantial burden of disease worldwide, causing lost productivity, increased healthcare costs, and reduced quality of life (QoL) in affected individuals.

Objective: To present the characteristics of urological patients over the last three years to determine a comprehensive strategy for managing related diseases.

Method: Retrospective cross-sectional study of patients at the Urology Polyclinic at Undata Regional Hospital, based on medical record data from January 2021 to December 2023, data was collected using a total sampling technique.

Results: This study consisted of 5223 total patients. Distribution based on age includes; 31.4% at age 61-70 years, 24.3% at age 51-60 years, 15.1% at age >70 years, 12.2% at age 41-50 years. As many as 7.3% at the age of 31-40 years, 5.1% at the age of 21-30 years, and 2.2% respectively at the age of <10 years and 11-20 years. Distribution based on gender includes; 81.2% of male patients and 18.8% of female patients. Distribution based on diagnosis includes; A total of 2988 research subjects, namely 57.2% with a diagnosis of prostatic hyperplasia, 16.7% with a diagnosis of kidney stones, and 6.8% with a diagnosis of ureteral stones.

Conclusion: Patients at the Urology Polyclinic at Undata Regional Hospital are generally elderly, most in the age range 61-70 years, followed by the age range 51-60 years, most of the patients are male and the most common diagnoses are prostatic hyperplasia, kidney stones and ureteral stones.

References

Mbibu NH, Nwofor AM, Khalid L. Spectrum of urologic disease in the West African sub region Annals of Afr Med. 2002;1:44–52.

Miller DC, Saigal CS, Litwin MS. The demographic burden of urologic diseases in America Urol Clin North Am. 2009;36:11–27.

Williams RD. Urologic diseases in America project J Urol. 2005;173:679.

Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: Benign prostatic hyperplasia J Urol. 2005;173:1256–61.

Pearle MS, Calhoun EA, Curhan GCUrologic Diseases of America P. . Urologic diseases in America project: Urolithiasis J Urol. 2005;173:848–57.

Issa MM, Fenter TC, Black L, Grogg AL, Kruep EJ. An assessment of the diagnosed prevalence of diseases in men 50 years of age or older Am J Manag Care. 2006;4(Suppl 12):S 83–9.

Population Division D, United Nations. World Population Aging 1950-2050. Executive Summary. [Internet] Available from: h t t p://www.un.org/esa/ population/publicati- ons/WPA2009/ WPA2009-report.pdf. Accessed: 26.11.2011.

Drach GW, Griebling TL. Geriatric urology. J Am Geriatr Soc 2003;51(7 Suppl):S355-8. (PMID:12823668).

De Nunzio C, Aronson W, Freedland SJ, Giovannucci E, Parsons JK. The Correlation Between Metabolic Syndrome and Prostatic Diseases. Eur Urol. 2012;61(3):560–70.

Miernik A, Gratzke C. Current Treatment for Benign Prostatic Hyperplasia. Dtsch Arztebl Int. 2020;117(49):843–54.

Haidinger G, Temml C, Schatzl G, et al. Risk factors for lower urinary tract symptoms in elderly men. For the prostate study group of the austrian society of urology. Eur Urol 2000;37(4):413-20. (PMID:10765071).

Barry MJ, Fowler FJ, O’leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. J Urol. 2017;197(2S):S189-97.

Malhotra V. Transurethral resection of the prostate. Anesthesi- ol Clin North America 2000;18(4):883-97. (PMID:11094696).

Nix JW, Carson CC. Medical management of benign prostatic hypertrophy. Can J Urol 2007;14(Suppl 1):53-7. (PMID:18163946).

McConnell JD, Roehrborn CG, Bautista OM, et al. The long- term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349(25):2387-98. (PMID:14681504).

Khalaf, K.M.; Coyne, K.S.; Globe, D.R.; Malone, D.C.; Armstrong, E.P.; Patel, V.; Burks, J. The impact of lower urinary tract symptoms on health-related quality of life among patients with multiple sclerosis. Neurourol. Urodyn. 2016, 35, 48–54.

Erkoc, M.; Otunctemur, A.; Besiroglu, H.; Altunrende, F. Evaluation of quality of life in patients undergoing surgery for benign prostatic hyperplasia. Aging Male 2018, 21, 238–242.

Liu, C.; Chen, H.; Xue, M.; Liu, H.; Deng, D.; Liufu, L.; Chen, R. Effect of continued self-efficacy health education after discharge on patients with benign prostatic hyperplasia. Mod. Clin. Nurs. 2016, 15, 70–74.